NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

… I think Dr. Linda Liau figured it out, too.

Not according to what is out there. On her Combo Phase 1 trials, LL is using the DCVax-L. At her talk at the UAB on November 6, 2020, LL says of the DCVax-L, "It is good for the patients." At the UCLA Brain Tumor Conference on December 4, 2020, one of LL's colleagues at the UCLA School of Medicine, Dr. Leia Nghiemphu said: "There are several vaccines out there. Here at UCLA, we use the dendritic cell vaccine." LL and her colleagues don't sound at all like they are peeved about the trial.